Patient retention in antiretroviral therapy programs up to three years on treatment in sub‐Saharan Africa, 2007–2009: systematic review

Abstract

Summary Objectives To estimate the proportion of all‐cause adult patient attrition from antiretroviral therapy (ART) programs in service delivery settings in sub‐Saharan Africa through 36 months on treatment. Methods We identified cohorts within Ovid Medline, ISI Web of Knowledge, Cochrane Database of Systematic Reviews and four conference abstract archives. We summarized retention rates from studies describing observational cohorts from sub‐Saharan Africa reporting on adult HIV 1‐ infected patients initiating first‐line three‐drug ART. We estimated all‐cause attrition rates for 6, 12, 18, 24, or 36 months after ART initiation including patients who died or were lost to follow‐up (as defined by the author), but excluding transferred patients. Results We analysed 33 sources describing 39 cohorts and 226 307 patients. Patients were more likely to be female (median 65%) and had a median age at initiation of 37 (range 34–40). Median starting CD4 count was 109 cells/mm 3 . Loss to follow‐up was the most common cause of attrition (59%), followed by death (41%). Median attrition at 12, 24 and 36 months was 22.6% (range 7%–45%), 25% (range 11%–32%) and 29.5% (range 13%–36.1%) respectively. After pooling data in a random‐effects meta‐analysis, retention declined from 86.1% at 6 months to 80.2% at 12 months, 76.8% at 24 months and 72.3% at 36 months. Adjusting for variable follow‐up time in a sensitivity analysis, 24 month retention was 70.0% (range: 66.7%–73.3%), while 36 month retention was 64.6% (range: 57.5%–72.1%). Conclusions Our findings document the difficulties in retaining patients in care for lifelong treatment, and the progress being made in raising overall retention rates.

Shown for reading. Its publisher allows quoting it, not republishing it.

References 53

1. 1.

   Ahoua L, Guenther G, Pinoges L, et al. Risk factors for virological failure and subtherapeutic antiretroviral drug concentrations in HIV-positive adults treated in rural northwestern Uganda. BMC Infectious Diseases. 2009;9:81.

   Not in our library10.1186/1471-2334-9-81

2. 2.

   Anglaret X, Toure S, Gourvellec G, et al. Impact of vital status investigation procedures on estimates of survival in cohorts of HIV-infected patients from Sub-Saharan Africa. Journal of Acquired Immune Deficiency Syndromes. 2004;35:320-323.

   Not in our library10.1097/00126334-200403010-00015

3. 3.

   Auld AF. Treatment Outcomes of HIV-Infected Adults Enrolled in the National Antiretroviral Therapy Program -Mozambique, 2004-2007. 2009.

   Not in our library

4. 4.

   Badri M, Cleary S, Maartens G, et al. When to initiate highly active antiretroviral therapy in sub-Saharan Africa? A South African cost-effectiveness study. Antiviral Therapy. 2006;11:63-72.

   Not in our library

5. 5.

   Bajunirwe F, Arts EJ, Tisch DJ, Debanne SM, Sethi AK. Survival, Adherence to Care and Antiretroviral Treatment (ART) Among HIV-Infected Adults in Rural Western Uganda. 2007.

   Not in our library

6. 6.

   Barth RE, Tempelman HA, Hoepelman AIM. Long-Term Follow Up of HIV-Infected Adults in Rural South Africa; Good Virological Results in Spite of Early Mortality. 2009.

   Not in our library

7. 7.

   Bisson G, Ndwapi N, Rollins C, et al. High Rates of Death Among Patients Lost to Follow-Up in Botswana's National Art Program: Implications for Monitoring and Evaluation. 2007.

   Not in our library

8. 8.

   Bisson GP, et al. Overestimates of survival after HAART: implications for global scale-up efforts. PLoS ONE. 2008;3:e1725.

   Not in our library10.1371/journal.pone.0001725

9. 9.

   Boulle A, Bock P, Osler M, et al. Antiretroviral therapy and early mortality in South Africa. Bulletin of the World Health Organization. 2008;86:678-687.

   Not in our library10.2471/blt.07.045294

10. 10.
    Mortality of Patients Lost to Follow-Up in Antiretroviral Treatment Programmes in Resource-Limited Settings: Systematic Review and Meta-Analysis · 2009

    No notice
11. 11.

    Bussmann H, Wester CW, Ndwapi N, et al. Five-year outcomes of initial patients treated in Botswana’s National Antiretroviral Treatment Program. AIDS. 2008;22:2303-2311.

    Not in our library10.1097/qad.0b013e3283129db0

12. 12.

    Chalamilla G. Predictors of Clinical and Immunological Outcomes among HIV-infected Subjects on ART in Tanzania. 2008.

    Not in our library

13. 13.

    Chang LVW, Alamo S, Guma S, et al. Two-Year Virologic Outcomes of an Alternative AIDS Care Model: evaluation of a Peer Health Worker and Nurse-Staffed Community-Based Program in Uganda. Journal of Acquired Immune Deficiency Syndromes. 2009;50:276-282.

    Not in our library10.1097/qai.0b013e3181988375

14. 14.

    Chi BH, Cantrell RA, Zulu I, et al. Adherence to first-line antiretroviral therapy affects non-virologic outcomes among patients on treatment for more than 12 months in Lusaka, Zambia. International Journal of Epidemiology. 2009;38:746-756.

    Not in our library10.1093/ije/dyp004

15. 15.

    Chiliade P. Long-term immunologic outcomes of patients started on antiretroviral therapy in 2 Sub-Saharan resource-limited countries. 2008.

    Not in our library

16. 16.

    Coetzee D, Hildebrand K, Boulle A, et al. Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa. AIDS. 2004;18:887-895.

    Not in our library10.1097/00002030-200404090-00006

17. 17.

    Collini P, Schwab U, Sarfo S, et al. Sustained immunological responses to highly active antiretroviral therapy at 36 months in a Ghanaian HIV cohort. Clinical Infectious Diseases. 2009;48:988-991.

    Not in our library10.1086/597353

18. 18.

    Culbert H, Tu D, O’Brien DP, et al. HIV treatment in a conflict setting: outcomes and experiences from Bukavu, Democratic Republic of the Congo. PLoS Medicine. 2007;4:e129.

    Not in our library10.1371/journal.pmed.0040129

19. 19.

    Dahab M. Off the radar screen: comparing reasons for treatment default in a workplace ART programme and a public sector clinic in South Africa. 2008.

    Not in our library

20. 20.

    DeSilva MB, Merry SP, Fischer PR, et al. Youth, unemployment, and male gender predict mortality in AIDS patients started on HAART in Nigeria. Aids Care-Psychological and Socio-Medical Aspects of Aids/HIV. 2009;21:70-77.

    Not in our library10.1080/09540120802017636

21. 21.

    Egger M, Davey Smith G, Altman DG. Systematic Reviews in Health Care: Meta-analysis in Context. 2001.

    Not in our library

22. 22.

    Egger M, May M, Chene G, et al. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet. 2002;360:119-129.

    Not in our library10.1016/s0140-6736(02)09411-4

23. 23.

    Fairall LR, Bachmann MO, Louwagie GM, et al. Effectiveness of antiretroviral treatment in a South African program: a cohort study. Archives of Internal Medicine. 2008;168:86-93.

    Not in our library10.1001/archinternmed.2007.10

24. 24.

    Fox MP, Brennan A, Maskew M, et al. Using Vital Registration Data to Update Mortality among Patients Lost to Follow-up from ART Programs: Evidence from the Themba Lethu Clinic, South Africa. Tropical Medicine and International Health. 2010;15:405-413.

    Not in our library10.1111/j.1365-3156.2010.02473.x

25. 25.

    Freeman MF, Tukey JW. Transformations related to the angular and the square root. Annals of the Institute of Statistical Mathematics. 1950;21:607-611.

    Not in our library

26. 26.

    Geng EH, Emenyonu N, Bwana MB, Glidden DV, Martin JN. Sampling-based approach to determining outcomes of patients lost to follow-up in antiretroviral therapy scale-up programs in Grimwood A (2008). 2008.

    Not in our library10.1001/jama.300.5.506

27. 27.

    Gugsa S. Determinants of retention and mortality during 6-month follow-up after initiation of HAART in an Ethiopian public HIV treatment program. 2008.

    Not in our library

28. 28.

    Ivers LC, Kendrick D, Doucette K. Efficacy of antiretroviral therapy programs in resource-poor settings: a meta-analysis of the published literature. Clinical Infectious Diseases. 2005;41:217-224.

    Not in our library10.1086/431199

29. 29.

    Jahn A. Antiretroviral regimen substitutions and switches due to drug toxicity and treatment failure: a national survey three years after the start of antiretroviral therapy roll-out in Malawi. 2008.

    Not in our library

30. 30.
    Predictors of mortality in HIV-infected patients starting antiretroviral therapy in a rural hospital in Tanzania · 2008

    No notice
31. 31.

    Kaplan R, Orrell C, Zwane E, Bekker LG, Wood R. Loss to follow-up and mortality among pregnant women referred to a community clinic for antiretroviral treatment. AIDS. 2008;22:1679-1681.

    Not in our library10.1097/qad.0b013e32830ebcee

32. 32.

    Keiser O, Anastos K, Schechter M, et al. Antiretroviral therapy in resource-limited settings 1996 to 2006: patient characteristics, treatment regimens and monitoring in sub-Saharan Africa, Asia and Latin America. Tropical Medicine and International Health. 2008;13:870-879.

    Not in our library10.1111/j.1365-3156.2008.02078.x

33. 33.

    Khan MSH. Retention and Attrition of Patients Commenced on HAART at Ladysmith Provincial Hospital in South Africa. 2009.

    Not in our library

34. 34.

    Laurent C, Ngom Gueye NF, Ndour CT, et al. Long-term benefits of highly active antiretroviral therapy in Senegalese HIV-1-infected adults. Journal of Acquired Immune Deficiency Syndromes. 2005;38:14-17.

    Not in our library10.1097/00126334-200501010-00003

35. 35.

    Lawn SD, Myer L, Wood R. Efficacy of antiretroviral therapy in resource-poor settings: are outcomes comparable to those in the developed world? Clinical Infectious Diseases. 2005;41:1683-1684.

    Not in our library10.1086/498030

36. 36.

    Lawn SD, Harries AD, Anglaret X, Myer L, Wood R. Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS. 2008;22:1897-1908.

    Not in our library10.1097/qad.0b013e32830007cd

37. 37.

    Lowrance DW, Ndamage F, Kayirangwa E, et al. Adult clinical and immunologic outcomes of the national antiretroviral treatment program in Rwanda during 2004–2005. Journal of Acquired Immune Deficiency Syndromes. 2009;52:49-55.

    Not in our library10.1097/qai.0b013e3181b03316

38. 38.

    MacPherson P, Moshabela M, Martinson N, Pronyk P. Mortality and loss to follow-up among HAART initiators in rural South Africa. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2009;103:588-593.

    Not in our library10.1016/j.trstmh.2008.10.001

39. 39.

    Marazzi MC, Liotta G, Germano P, et al. Excessive early mortality in the first year of treatment in HIV type 1-infected patients initiating antiretroviral therapy in resource-limited settings. AIDS Research and Human Retroviruses. 2008;24:555-560.

    Not in our library10.1089/aid.2007.0217

40. 40.

    Martin J. Initial Treatment Outcomes from a Rural-based ART Scale-up Program in East Africa: The UARTO Cohort. 2008.

    Not in our library

41. 41.

    Mocroft AJ, Lundgren JD, d’Armino MA, et al. Survival of AIDS patients according to type of AIDS-defining event. The AIDS in Europe Study Group. International Journal of Epidemiology. 1997;26:400-407.

    Not in our library10.1093/ije/26.2.400

42. 42.

    Morgan D, Mahe C, Mayanja B, et al. HIV-1 infection in rural Africa: is there a difference in median time to AIDS and survival compared with that in industrialized countries? AIDS. 2002;16:597-603.

    Not in our library10.1097/00002030-200203080-00011

43. 43.

    Nachega JB, Hislop M, Dowdy DW, et al. Efavirenz versus nevirapine-based initial treatment of HIV infection: clinical and virological outcomes in Southern African adults. AIDS. 2008;22:2117-2125.

    Not in our library10.1097/qad.0b013e328310407e

44. 44.

    O’Brien DP, Mills C, Hamel C, Ford N, Pottie K. Universal access: the benefits and challenges in bringing integrated HIV care to isolated and conflict affected populations in the Republic of Congo. Conflict and Health. 2009;3:1.

    Not in our library10.1186/1752-1505-3-1

45. 45.

    Ojikutu BO, Zheng H, Walensky RP, et al. Predictors of mortality in patients initiating antiretroviral therapy in Durban, South Africa. South African Medical Journal. 2008;98:204-208.

    Not in our library

46. 46.

    Palombi L, Marazzi MC, Guidotti G, et al. Incidence and Predictors of Death, Retention, and Switch to Second-Line Regimens in Antiretroviral-Treated Patients in Sub-Saharan African Sites with Comprehensive Monitoring Availability. Clinical Infectious Diseases. 2009;48:115-122.

    Not in our library10.1086/593312

47. 47.
    Patient Retention in Antiretroviral Therapy Programs in Sub-Saharan Africa: A Systematic Review · 2007

    No notice
48. 48.

    Rosen S, Long L, Sanne I. The outcomes and outpatient costs of different models of antiretroviral treatment delivery in South Africa. Tropical Medicine and International Health. 2008;13:1005-1015.

    Not in our library10.1111/j.1365-3156.2008.02114.x

49. 49.

    Sieleunou I, Souleymanou M, Schonenberger AM, Menten J, Boelaert M. Determinants of survival in AIDS patients on antiretroviral therapy in a rural centre in the Far-North Province, Cameroon. Tropical Medicine and International Health. 2009;14:36-43.

    Not in our library10.1111/j.1365-3156.2008.02183.x

50. 50.

    Souteyrand Y, Akwara P, Warner Smith M, et al. Scaling up access to antiretroviral therapy (ART) in low- and middle-income countries: global and regional progress in 2008. 2009.

    Not in our library

51. 51.

    Toure S, Kouadio B, Seyler C, et al. Rapid scaling-up of antiretroviral therapy in 10000 adults in Cote d’Ivoire: 2-year outcomes and determinants. AIDS. 2008;22:873-882.

    Not in our library10.1097/qad.0b013e3282f768f8

52. 52.

    Unge C, Sodergard B, Ekstrom AM, et al. Challenges for scaling up ART in a resource-limited setting: a retrospective study in kibera, Kenya. Jaids-Journal of Acquired Immune Deficiency Syndromes. 2009;50:397-402.

    Not in our library10.1097/qai.0b013e318194618e

53. 53.
    Sampling-based approaches to improve estimation of mortality among patient dropouts: experience from a large PEPFAR-funded program in Western Kenya. · 2008

    Not checked

Cited by papers we hold 11

• Incidence and predictors of loss to follow up among adult HIV patients on antiretroviral therapy in University of Gondar Comprehensive Specialized Hospital: A competing risk regression modeling. · 2020
  Not checked
• A Second Look at the Association between Gender and Mortality on Antiretroviral Therapy. · 2015
  Not checked
• Adherence to antiretroviral therapy and retention in care for adolescents living with HIV from 10 districts in Uganda · 2015
  No notice
• HPTN 071 (PopART): Rationale and design of a cluster-randomised trial of the population impact of an HIV combination prevention intervention including universal testing and treatment – a study protocol for a cluster randomised trial · 2014
  No notice
• Antiretroviral therapy uptake, attrition, adherence and outcomes among HIV-infected female sex workers: a systematic review and meta-analysis. · 2014
  Not checked
• Multi-Level Factors Affecting Entry into and Engagement in the HIV Continuum of Care in Iringa, Tanzania · 2014
  No notice
• Toward an Understanding of Disengagement from HIV Treatment and Care in Sub-Saharan Africa: A Qualitative Study · 2013
  No notice
• Life Expectancies of South African Adults Starting Antiretroviral Treatment: Collaborative Analysis of Cohort Studies · 2013
  No notice
• Expanding ART for Treatment and Prevention of HIV in South Africa: Estimated Cost and Cost-Effectiveness 2011-2050 · 2012
  No notice
• Universal Definition of Loss to Follow-Up in HIV Treatment Programs: A Statistical Analysis of 111 Facilities in Africa, Asia, and Latin America · 2011
  No notice
• Retention in HIV Care between Testing and Treatment in Sub-Saharan Africa: A Systematic Review · 2011
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.